Sydnor, S., Chatterjee, S., Cooney, P., Kaur, S., Macmillan, T., Stewart, D., . . . Felizzi, F. (2023). Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis. Diabetes therapy, 14(7), 1193-1216. https://doi.org/10.1007/s13300-023-01410-8
Chicago Style (17th ed.) CitationSydnor, Shelby, et al. "Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis." Diabetes Therapy 14, no. 7 (2023): 1193-1216. https://doi.org/10.1007/s13300-023-01410-8.
MLA (9th ed.) CitationSydnor, Shelby, et al. "Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis." Diabetes Therapy, vol. 14, no. 7, 2023, pp. 1193-1216, https://doi.org/10.1007/s13300-023-01410-8.